Regulatory Considerations For The mRNA Platform

Regulatory compliance is a top concern for mRNA therapeutics due to several key factors from an unclear regulatory framework to long-term safety monitoring. In this segment, Joseph Barberio, VP Technical Operations at Strand Therapeutics and Christian Moreno, Director of Supply Chain Management at Nutcracker Therapeutics share how their companies ensure data integrity and privacy compliance throughout R&D and manufacturing. Specifically, we cover Strand’s key regulatory considerations for your mRNA platform as well as the strategies Nutcracker employs to stay updated on evolving regulatory guidelines for mRNA therapeutics and ensure ongoing compliance.